The DOI matches its Crossref record; 95 of the 98 references it cites were found in a registry or an index.
Myostatin: more than just a regulator of muscle mass
Abstract
The presence of sufficient skeletal muscle mass is of paramount importance for body function and the myostatin cascade is known to inhibit muscle growth in mammals. In addition, myostatin seems to have an important role in the cross-talk between skeletal muscle and adipose tissue and is involved in insulin sensitivity. In this article we highlight the latest developments related to the myostatin system, emphasizing therapeutic implications for wasting diseases and also the involvement of the system in other organs, in addition to skeletal muscle, such as heart or adipose tissue. Moreover, we highlight the possible role of the myostatin system in the cross-talk between skeletal muscle and adipose tissue, an important aspect that deserves consideration in wasting diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it is known today that myostatin is also expressed and secreted even in adulthood (Argiles et al., 2012).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Argiles et al., 2012
In the citing paper
“Myostatin was first described to be secreted during development to limit muscle growth 143, but is also known today to be produced in adults 144, and to promote muscle atrophy, in part by inhibiting AKT and mTOR signaling.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [144]
In the citing paper
“Myostatin was first described to be secreted during development to limit muscle growth 143, but is also known today to be produced in adults 144, and to promote muscle atrophy, in part by inhibiting AKT and mTOR signaling.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [144]
Citations
Cites
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Evans, W., Morley, J., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,341
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T. C., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 960
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910
Induction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P. A., Esquela‐Kerscher, A., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S. (2002) · Science · doi:10.1126/science.1069525 · Cited by 908
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia
Das, S. K., Eder, S., Schauer, S., Diwoky, C., Temmel, H., Guertl, B., Gorkiewicz, G., Tamilarasan, K. P., Kumari, P., Trauner, M., et al. (2011) · Science · doi:10.1126/science.1198973 · Cited by 594
Flagged first, then by citations
3 of the 98 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cancer cachexia: understanding the molecular basis
Argilés, J. M. A., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3829 · Cited by 1,567
Leal, L. G., Lopes, M. A., & Batista, M. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01307 · Cited by 382
“However, it is known today that myostatin is also expressed and secreted even in adulthood (Argiles et al., 2012).”
BackgroundCancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
da Silva, S. P., Santos, J., Silva, M. P. C. E., da Costa, R. M. G., & Medeiros, R. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 392
Inter-tissue communication in cancer cachexia
Argilés, J. M. A., Stemmler, B., López-Soriano, F. J., & Busquets, S. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0123-0 · Cited by 317
Shan, T., Liang, X., Bi, P., & Kuang, S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225755 · Cited by 301
Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Jiménez-Gutiérrez, G. E., Martínez-Gómez, L. E., Martínez-Armenta, C., Pineda, C., Martínez‐Nava, G. A., & López-Reyes, A. G. (2022) · Cells · doi:10.3390/cells11152359 · Cited by 245
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
Smith, R. C., & Lin, B. K. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000013 · Cited by 161
Sarcopenic obesity: how do we treat it?
Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141
Myokines and Resistance Training: A Narrative Review
Zunner, B. E. M., Wachsmuth, N. B., Eckstein, M. L., Scherl, L., Schierbauer, J., Haupt, S., Stumpf, C., Reusch, L., & Moser, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073501 · Cited by 146
Cachexia-associated adipose tissue morphological rearrangement in gastrointestinal cancer patients
Júnior, M. L. B., Henriques, F. D. S., das Neves, R. X., Oliván, M., de Matos‐Neto, E. M., de Alcântara, P. S. M., Maximiano, L. F., Otoch, J. P., Alves, M. J., & Seelaender, M. C. L. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12037 · Cited by 116
Mueller, T. C., Bachmann, J., Prokopchuk, O., Friess, H., & Martignoni, M. E. (2016) · BMC Cancer · doi:10.1186/s12885-016-2121-8 · Cited by 95
Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy
Rooks, D. S., Laurent, D., Praestgaard, J., Rasmussen, S., Bartlett, M., & Tankó, L. B. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12205 · Cited by 90
Marceca, G. P., Londhe, P., & Calore, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00298 · Cited by 92
Cole, C. L., Kleckner, I. R., Jatoi, A., Schwarz, E. M., & Dunne, R. F. (2018) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v3i2.65 · Cited by 84
Myostatin – The Holy Grail for Muscle, Bone, and Fat?
Buehring, B., & Binkley, N. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0160-5 · Cited by 79
Harper (2016) · doi:10.1161/circresaha.116.307962 · Cited by 74
Mediators of cachexia in cancer patients
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.012 · Cited by 75
Martı́n, A. I., Priego, T., & López‐Calderón, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_9 · Cited by 84
Miroshnychenko, O., Chang, W., & Dragoo, J. L. (2016) · The American Journal of Sports Medicine · doi:10.1177/0363546516677547 · Cited by 70
Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management
Siff, T. E., Parajuli, P., Razzaque, M. S., & Atfi, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.03.007 · Cited by 73
Advances in research on pharmacotherapy of sarcopenia
Feike, Y., Liu, Z., & Chen, W. (2021) · Aging Medicine · doi:10.1002/agm2.12168 · Cited by 67
Vamvini, M. T., Aronis, K. N., Panagiotou, G., Huh, J. Y., Chamberland, J. P., Brinkoetter, M. T., Petrou, M., Christophi, C. A., Kales, S. N., Christiani, D. C., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0276 · Cited by 65
Tao, J. J., Cangemi, N. A., Makker, V., Cadoo, K. A., Liu, J. F., Rasco, D. W., Navarro, W. H., Haqq, C. M., & Hyman, D. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1065 · Cited by 60
Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy
Saitoh, M., Ishida, J., Ebner, N., Anker, S. D., Springer, J., & von Haehling, S. (2017) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v2i1.37 · Cited by 60
Pharmacological prospects in the treatment of Duchenne muscular dystrophy
Rüegg, U. T. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328364fbaf · Cited by 56
Duchenne muscular dystrophy: an updated review of common available therapies
Salmaninejad, A., Valilou, S. F., Bayat, H., Ebadi, N., Daraei, A., Yousefi, M., Nesaei, A., & Mojarrad, M. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1430694 · Cited by 59
Myostatin — From the Mighty Mouse to cardiovascular disease and cachexia
Dschietzig, T. B. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.021 · Cited by 55
Qi, H., Ren, J., Ba, L., Song, C., Zhang, Q., Cao, Y., Shi, P., Fu, B., Liu, Y., & Sun, H. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.003 · Cited by 54
Low-intensity pulsed ultrasound prevents muscle atrophy induced by type 1 diabetes in rats
Tang, L., Li, N., Jian, W., Kang, Y., Yin, B., Sun, S., Guo, J., Sun, L., & Ta, D. (2017) · Skeletal Muscle · doi:10.1186/s13395-017-0145-7 · Cited by 50
Freire, P. P., Fernández, G. J., Cury, S. S., de Moraes, D., Oliveira, J. S., de Oliveira, G., Dal‐Pai‐Silva, M., Reis, P. P., & Carvalho, R. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081962 · Cited by 45
Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells
Chang, H., Fang, L., Cheng, J., Klausen, C., Sun, Y., & Leung, P. C. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.036 · Cited by 45
Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection
Silva, J. M. D. S., Alabarse, P. V. G., Teixeira, V. D. O. N., Freitas, E. C., de Oliveira, F. H., Chakr, R. M. D. S., & Xavier, R. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196682 · Cited by 45
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis
Little, R. D., Prieto‐Potín, I., Pérez-Baos, S., Villalvilla, A., Gratal, P., Cicuttini, F., Largo, R., & Herrero‐Beaumont, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-06581-6 · Cited by 44
Lee, E. J., Ahmad, S. S., Lim, J. H., Ahmad, K., Shaikh, S., Lee, Y., Park, S. J., Jin, J., Lee, Y., & Choi, I. (2021) · Cells · doi:10.3390/cells10082083 · Cited by 46
Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia
Padrão, A. I., Moreira‐Gonçalves, D., Oliveira, P. A., Teixeira, C., Faustino‐Rocha, A. I., Helguero, L. A., Vitorino, R. M. P., Santos, L. L., Amado, F. M. L., Duarte, J. A., et al. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.12.026 · Cited by 43
Graça, F. A., Rai, M., Hunt, L. C., Stephan, A., Wang, Y., Gordon, B., Wang, R., Quarato, G., Xu, B., Fan, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30120-1 · Cited by 41
Establishment and phenotypic analysis of an Mstn knockout rat
Gu, H., Cao, Y., Qiu, B., Zhou, Z., Deng, R., Chen, Z., Li, R., Li, X., Wei, Q., Xia, X., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.030 · Cited by 40
Yang, S., Li, X., Liu, X., Ding, X., Xin, X., Jin, C., Zhang, S., Li, G., & Guo, H. (2018) · Oncotarget · doi:10.18632/oncotarget.24250 · Cited by 39
Yamakage, H., Tanaka, M., Inoue, T., Odori, S., Kusakabe, T., & Satoh‐Asahara, N. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13179 · Cited by 39
Xin, X., Yang, S., Li, X., Liu, X., Zhang, L.-L., Ding, X., Zhang, S., Li, G., & Guo, H. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.113237 · Cited by 37
Miao, C., Lv, Y., Zhang, W., Chai, X., Feng, L., Fang, Y., Liu, X., & Zhang, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00915 · Cited by 37
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
Wang, Y., Wu, L.-L., Qi, X.-Y., Wang, Y.-Y., Liao, Z., Liu, J., & Xiao, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.013 · Cited by 36
Implication of diet and exercise on the management of age‐related sarcopenic obesity in Asians
Kim, Y. J., Moon, S., Yu, J. M., & Chung, H. S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14442 · Cited by 36
The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts
Dragoo, J. L. (2016) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967116s00150 · Cited by 34
Tanaka, M., Masuda, S., Yamakage, H., Inoue, T., Ohue‐Kitano, R., Yokota, S., Kusakabe, T., Wada, H., Sanada, K., Ishii, K., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.041 · Cited by 32
Han, Y.-Q., Ming, S., Wu, H.-T., Zeng, L., Ba, G., Li, J., Lu, W., Han, J., Du, Q., Sun, M., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.009 · Cited by 32
The Role of Adipocytokines in Atherogenesis and Atheroprogression
Carbone, F., Mach, F., & Montecucco, F. (2015) · Current Drug Targets · doi:10.2174/1389450115666141109213439 · Cited by 31
Argilés, J. M. A. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.05.010 · Cited by 31
Gomes, C. P. C., de Gonzalo‐Calvo, D., Toro, R., Fernandes, T. M., Theisen, D., Wang, D., Devaux, Y., & on behalf of the Cardiolinc™ network (2018) · Clinical Science · doi:10.1042/cs20171463 · Cited by 31
Hepatocyte Growth Factor and Satellite Cell Activation
Anderson, J. E. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_1 · Cited by 30
Leal, L. G., Lopes, M. A., Peres, S. B., & Júnior, M. L. B. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.570170 · Cited by 30
Cancer cachexia, a clinical challenge
Argilés, J. M. A., Busquets, S., & López-Soriano, F. J. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000517 · Cited by 28
Cui, Y., Yi, Q., Sun, W., Huang, D., Zhang, H., Duan, L., Shang, H., Wang, D., & Xiong, J. (2020) · BioFactors · doi:10.1002/biof.1675 · Cited by 30
Sarcopenia in chronic kidney disease: from bench to bedside
Kim, D. W., & Song, S. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.338 · Cited by 32
Hoffman, M. L., Peck, K. N., Wegrzyn, J., Reed, S. A., Zinn, S. A., & Govoni, K. E. (2016) · Journal of Animal Science · doi:10.2527/jas.2016-0570 · Cited by 28
Méloux, A., Rochette, L., Maza, M., Bichât, F., Tribouillard, L., Cottin, Y., Zeller, M., & Vergely, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010116 · Cited by 27
Nitric oxide treatment attenuates muscle atrophy during hind limb suspension in mice
Anderson, J. E., Zhu, A., & Mizuno, T. M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.021 · Cited by 25
Li, Y., Wang, Y., Willems, E., Willemsen, H., Franssens, L., Buyse, J., Decuypere, E., & Everaert, N. (2015) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12299 · Cited by 25
Ge, L., Dong, X., Gong, X., Kang, J., Zhang, Y., & Quan, F. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.043 · Cited by 25
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety
Garutti, M., Sirico, M., Noto, C., Foffano, L., Hopkins, M., & Puglisi, F. (2025) · Current Obesity Reports · doi:10.1007/s13679-024-00604-w · Cited by 30
The role of extracellular vesicles in skeletal muscle wasting
Zhang, X., Zhao, Y., & Yan, W. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13364 · Cited by 24
Shabani, R., & Izaddoust, F. (2018) · Acta Gymnica · doi:10.5507/ag.2018.007 · Cited by 23
Raimondo, D. D., Miceli, G., Musiari, G., Tuttolomondo, M., & Pinto, A. V. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.07.30 · Cited by 24
Yang, H., Luo, L.-J., Chen, W.-J., Zhao, L., Tang, C., Qi, Y., & Zhang, J. (2014) · Endocrine · doi:10.1007/s12020-014-0233-y · Cited by 22
Single nucleotide polymorphisms in the upstream regulatory region alter the expression of myostatin
Hu, W., Chen, S., Zhang, R., & Lin, Y. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-013-9621-5 · Cited by 22
Treatment to Improve Nutrition and Functional Capacity Evaluation in Liver Transplant Candidates
Dasarathy, S. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0016-9 · Cited by 22
Epigenetics of cancer-associated muscle catabolism
Carr, R. M., Enriquez-Hesles, E., Olson, R. L., Jatoi, A., Doles, J. D., & Fernández-Zapico, M. E. (2017) · Epigenomics · doi:10.2217/epi-2017-0058 · Cited by 18
Kaur, M., & Misra, S. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2024-0065 · Cited by 17
Featured characteristics and pivotal roles of satellite cells in skeletal muscle regeneration
Song, T., & Sadayappan, S. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09553-7 · Cited by 20
Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs
Renzini, A., D’Onghia, M., Coletti, D., & Moresi, V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.706003 · Cited by 15
Nutritional Considerations in Preventing Muscle Atrophy
Creţoiu, S. M., & Zugravu, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_23 · Cited by 17
Myostatin site‐directed mutation and simultaneous PPARγ site‐directed knockin in bovine genome
Ge, L., Kang, J., Dong, X., Luan, D., Su, G., Li, G., Zhang, Y., & Quan, F. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30017 · Cited by 15
“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 14
Major determinants of circulating myostatin in polycystic ovary syndrome
Arpacı, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7080 · Cited by 14
Kramerova, I. A., Marinov, M., Owens, J. M., Lee, S., Becerra, D., & Spencer, M. J. (2020) · The Journal of Physiology · doi:10.1113/jp279943 · Cited by 14
Zhu, C., Liu, G., Gu, X., Yin, J., Xia, A., Han, M., Zhang, T., & Jiang, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.938526 · Cited by 14
Effect of eccentric contraction on satellite cell activation in human vastus lateralis muscle
Imaoka, Y., Kawai, M., Mori, F., & Miyata, H. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0385-4 · Cited by 14
Targeting Unique Epitopes on Highly Similar Proteins GDF-11 and GDF-8 with Modified DNA Aptamers
Ochsner, U. A., Green, L. S., Rice, T., Olivas, E., Janjić, N., & Katilius, E. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00760 · Cited by 14
Bonnet, M., Tournayre, J., & Cassar‐Malek, I. (2016) · Molecular BioSystems · doi:10.1039/c6mb00224b · Cited by 12
Kovanecz, I., Masouminia, M., Gelfand, R., Vernet, D. A., Rajfer, J., & González-Cadavid, N. F. (2017) · International Journal of Impotence Research · doi:10.1038/ijir.2017.22 · Cited by 12
Myostatin's marvels: From muscle regulator to diverse implications in health and disease
Sharma, S., & Patil, A. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4106 · Cited by 12
Tammam, A. A.-E., Rizg, W. Y., Boushra, A. F., Alhelf, M., Alissa, M., Soliman, G. F., Ouais, G. N., Hosny, K. M., Alkhalidi, H. M., & Elebiary, A. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1228525 · Cited by 10
Irisin and Myostatin Levels in Patients with Graves' Disease
Yalçın, M. M., Aktürk, M., Tohma, Y., Cerit, E. T., Altınova, A. E., Arslan, E., Yetkin, İ., & Törüner, F. B. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.11.002 · Cited by 10
Swan, J., Szabó, Z., Peters, J., Kummu, O., Kemppi, A., Rahtu‐Korpela, L., Konzack, A., Hakkola, J., Pasternack, A. H., Ritvos, O., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116683 · Cited by 9
Li, F., Shan, A. S., Hu, J., Zheng, Y.-L., Xu, L., & Chen, Z. H. (2013) · British Poultry Science · doi:10.1080/00071668.2013.853868 · Cited by 9
Turcotte, L. M., DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.236 · Cited by 8
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients
Mackels, L., Mariot, V., Buscemi, L., Servais, L., & Dumonceaux, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168763 · Cited by 8
Anderson, L. B., Ravara, B., Hameed, S., Latour, C. D., Latour, S. M., Graham, V. M., Hashmi, M. N., Cobb, B. A., Dethrow, N. M., Urazaev, A. K., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab062 · Cited by 10
Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and Polymyositis
de Sordi, C. M., dos Reis-Neto, E. T., Keppeke, G. D., Shinjo, S. K., & Sato, E. I. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001806 · Cited by 12
Santos, H. O., Cerqueira, H. S. C., & Tinsley, G. M. (2022) · Metabolites · doi:10.3390/metabo12111146 · Cited by 8
Patalong-Wójcik, M., Golara, A., Zając, K., Sokołowska, A., Kozłowski, M., Tołoczko‐Grabarek, A., Krzyścin, M., Brodowska, A., Janiec, A., Myszka, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061574 · Cited by 7
Berstein, L. M., Евгеньевна, П. Т., & Vasilyev, D. A. (2017) · Obesity and metabolism · doi:10.14341/omet2017135-40 · Cited by 6
Chiang, J., Lin, L., Wu, C., Hwang, J., Yang, W., & Wu, Y. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.09.024 · Cited by 6
Khan, M. H., Fatima, M., Adnan, A. B., Jawaid, A., Hassan, S. M., Talal, M., Rahim, S., Mughal, Z. U. N., Patel, A. O., & Singh, A. K. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003584 · Cited by 9
Bonnet, M., Kaspric, N., Vonnahme, K. A., Viala, D., Chambon, C., & Picard, B. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124375 · Cited by 5
Editorial: The Fall of Mechanogrowth Factor?
Rotwein, P. S. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1411 · Cited by 5
Lima, W. P. (2017) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfe.v16i2.972 · Cited by 3
Bonnet, M., Louveau, I., Cassar‐Malek, I., Lefaucheur, L., & Rescan, P. (2020) · INRAE Productions Animales · doi:10.20870/productions-animales.2015.28.2.3021 · Cited by 3
Metadata
- Authors
- Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J.
- Affiliations
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Universitat de Barcelona (ES)
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 17
- Issue
- 13-14
- Pages
- 702-709
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1975544443
- Cited by
- 125
- References
- 98
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 14 · 2017: 13 · 2016: 13 · 2015: 9 · 2014: 10 · 2013: 8
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- myostatin, skeletal muscle mass, insulin sensitivity, wasting disease, muscle atrophy, heart, adipose tissue, therapeutic target
- MeSH terms
- Adipose Tissue, Animals, Cachexia, Exercise Therapy, Glucocorticoids, Humans, Insulin Resistance, Organ Size, Muscle, Skeletal, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review